Drugs, Poisons and Controlled Substances Regulations 2017
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Drugs, Poisons and Controlled Substances Regulations 2017
Start here
Turn the raw legal text into a practical explanation grounded in Drugs, Poisons and Controlled Substances Regulations 2017.
133F Possession and supply of Schedule 3 naloxone by approved naloxone provider
(1) An approved naloxone provider is authorised to obtain and to possess Schedule 3 naloxone—
(a) for the purpose of facilitating the supply of the naloxone, for the treatment of opioid overdoses, by approved naloxone workers who are engaged by the provider; and
(b) in accordance with the conditions (if any) specified in the provider's approval under regulation 161D.
Reg. 133F(2) amended by S.R. No. 126/2024 reg. 13(1).
(2) Subject to subregulation (3), an approved naloxone provider is authorised to supply Schedule 3 naloxone to an approved naloxone worker who is engaged by the provider if that supply is—
(a) for the purpose of facilitating the supply of the naloxone, for the treatment of opioid overdoses, by the worker; and
(b) in accordance with the conditions (if any) specified in the provider's approval under regulation 161D.
(3) An approved naloxone provider that supplies Schedule 3 naloxone to an approved naloxone worker who is engaged by the provider must place a label on the container which uniquely identifies the provider.
Reg. 133F(3A) inserted by S.R. No. 126/2024 reg. 13(2).
(3A) Subject to subregulation (3B), an approved naloxone provider is authorised to supply Schedule 3 naloxone for the treatment of opioid overdose by means of an automatic machine if that supply is in accordance with the conditions (if any) specified in the provider's approval under regulation 161D.
Reg. 133F(3B) inserted by S.R. No. 126/2024 reg. 13(2).
(3B) An approved naloxone provider must not place Schedule 3 naloxone into an automatic machine by means of which the naloxone is to be supplied for the treatment of opioid overdose unless the naloxone is in a container on which there is a label that uniquely identifies the provider.
(4) An agent of an approved naloxone provider is authorised to obtain, possess and supply Schedule 3 naloxone as an agent of that provider and to the extent and for the purpose permitted by this regulation.
Reg. 133G inserted by S.R. No. 113/2022 reg. 6.